CATH Superfamily 3.30.60.30
The name of this superfamily has been modified since the most recent official CATH+ release (v4_2_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 4606: Agrin isoform 1-like protein
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 34 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
17 |
A2ASQ1 (/IPI)
A2ASQ1 (/IPI)
A2ASQ1 (/IPI)
O00468 (/IPI)
O00468 (/IPI)
O00468 (/IPI)
O00468 (/IPI)
O00468 (/IPI)
O95633 (/IPI)
P25304 (/IPI)
(7 more) |
|
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
13 |
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
(3 more) |
|
Sialic acid binding GO:0033691
Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.
|
13 |
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
(3 more) |
|
Heparan sulfate proteoglycan binding GO:0043395
Interacting selectively and non-covalently with a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
|
13 |
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
(3 more) |
|
Chondroitin sulfate binding GO:0035374
Interacting selectively and non-covalently with chondroitin sulfate, a glycosaminoglycan made up of two alternating monosaccharides: D-glucuronic acid (GlcA) and N-acetyl-D-galactosamine (GalNAc).
|
10 | O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) |
|
Dystroglycan binding GO:0002162
Interacting selectively and non-covalently with dystroglycan. Dystroglycan is glycoprotein found in non-muscle tissues as well as in muscle tissues, often in association with dystrophin. The native dystroglycan cleaved into two non-covalently associated subunits, alpha (N-terminal) and beta (C-terminal).
|
9 | A0A1D5PHC7 (/IPI) A0A1D5PHC7 (/IPI) A0A1D5PHC7 (/IPI) A0A1D5PHC7 (/IPI) A0A1D5PHC7 (/IPI) G5EG68 (/IPI) P31696 (/IPI) P31696 (/IPI) P31696 (/IPI) |
|
Dystroglycan binding GO:0002162
Interacting selectively and non-covalently with dystroglycan. Dystroglycan is glycoprotein found in non-muscle tissues as well as in muscle tissues, often in association with dystrophin. The native dystroglycan cleaved into two non-covalently associated subunits, alpha (N-terminal) and beta (C-terminal).
|
8 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Dystroglycan binding GO:0002162
Interacting selectively and non-covalently with dystroglycan. Dystroglycan is glycoprotein found in non-muscle tissues as well as in muscle tissues, often in association with dystrophin. The native dystroglycan cleaved into two non-covalently associated subunits, alpha (N-terminal) and beta (C-terminal).
|
8 | A2ASQ1 (/ISS) A2ASQ1 (/ISS) A2ASQ1 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) |
|
Calcium ion binding GO:0005509
Interacting selectively and non-covalently with calcium ions (Ca2+).
|
8 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Glycosaminoglycan binding GO:0005539
Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
|
8 | A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Acetylcholine receptor regulator activity GO:0030548
Interacting (directly or indirectly) with acetylcholine receptors such that the proportion of receptors in the active form is changed.
|
8 | A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Laminin-1 binding GO:0043237
Interacting selectively and non-covalently with laminin-1, a glycoprotein trimer with the subunit composition alpha1, beta1, gamma1.
|
8 | A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Extracellular matrix binding GO:0050840
Interacting selectively and non-covalently with a component of the extracellular matrix.
|
8 | A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Acetylcholine receptor regulator activity GO:0030548
Interacting (directly or indirectly) with acetylcholine receptors such that the proportion of receptors in the active form is changed.
|
6 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Chondroitin sulfate binding GO:0035374
Interacting selectively and non-covalently with chondroitin sulfate, a glycosaminoglycan made up of two alternating monosaccharides: D-glucuronic acid (GlcA) and N-acetyl-D-galactosamine (GalNAc).
|
6 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Heparan sulfate proteoglycan binding GO:0043395
Interacting selectively and non-covalently with a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
|
6 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Structural constituent of cytoskeleton GO:0005200
The action of a molecule that contributes to the structural integrity of a cytoskeletal structure.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
BMP binding GO:0036122
Interacting selectively and non-covalently with a member of the bone morphogenetic protein (BMP) family.
|
5 | P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) |
|
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
5 | P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) P25304 (/IPI) |
|
Receptor activity GO:0004872
Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
|
3 | P31696 (/TAS) P31696 (/TAS) P31696 (/TAS) |
|
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Transmembrane receptor protein tyrosine kinase activator activity GO:0030297
Binds to and increases the activity of a transmembrane receptor protein tyrosine kinase.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Sialic acid binding GO:0033691
Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
ATPase inhibitor activity GO:0042030
Stops, prevents or reduces the activity of any enzyme that catalyzes the hydrolysis of ATP to ADP and orthophosphate.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Laminin binding GO:0043236
Interacting selectively and non-covalently with laminins, glycoproteins that are major constituents of the basement membrane of cells.
|
3 | P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Laminin-1 binding GO:0043237
Interacting selectively and non-covalently with laminin-1, a glycoprotein trimer with the subunit composition alpha1, beta1, gamma1.
|
3 | P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Ion channel binding GO:0044325
Interacting selectively and non-covalently with one or more specific sites on an ion channel, a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.
|
3 | A2ASQ1 (/IPI) A2ASQ1 (/IPI) A2ASQ1 (/IPI) |
|
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
1 | O95633 (/IPI) |
|
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
|
1 | Q9EQC7 (/ISO) |
|
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
1 | Q9EQC7 (/IDA) |
|
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
1 | O95633 (/IPI) |
|
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
1 | Q9EQC7 (/ISO) |
There are 81 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
|
16 |
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
O00468 (/IDA)
O00468 (/IDA)
O00468 (/IDA)
O00468 (/IDA)
O00468 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
(6 more) |
|
Axonogenesis GO:0007409
De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon.
|
13 |
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
F1R074 (/IMP)
(3 more) |
|
Central nervous system development GO:0007417
The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
|
13 |
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
F1R074 (/IMP)
(3 more) |
|
Peripheral nervous system development GO:0007422
The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
|
13 |
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
F1R074 (/IMP)
(3 more) |
|
Neuromuscular junction development GO:0007528
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction.
|
13 |
A0A1D5PHC7 (/TAS)
A0A1D5PHC7 (/TAS)
A0A1D5PHC7 (/TAS)
A0A1D5PHC7 (/TAS)
A0A1D5PHC7 (/TAS)
P25304 (/TAS)
P25304 (/TAS)
P25304 (/TAS)
P25304 (/TAS)
P25304 (/TAS)
(3 more) |
|
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
13 |
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IJ40 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
A0A0R4IPG9 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
B3GQ72 (/IMP)
F1R074 (/IMP)
(3 more) |
|
Positive regulation of synaptic growth at neuromuscular junction GO:0045887
Any process that activates or increases the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
13 |
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
P25304 (/ISS)
(3 more) |
|
Skeletal muscle acetylcholine-gated channel clustering GO:0071340
The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals.
|
13 |
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
(3 more) |
|
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
11 |
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P31696 (/ISS)
P31696 (/ISS)
(1 more) |
|
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
11 |
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
A2ASQ1 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
O00468 (/ISS)
P31696 (/ISS)
P31696 (/ISS)
(1 more) |
|
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
9 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) O95633 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Glycosaminoglycan biosynthetic process GO:0006024
The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
|
8 | A2ASQ1 (/TAS) A2ASQ1 (/TAS) A2ASQ1 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Neuron cell-cell adhesion GO:0007158
The attachment of a neuron to another cell via adhesion molecules.
|
8 | A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) P31696 (/TAS) P31696 (/TAS) P31696 (/TAS) |
|
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
8 | A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
8 | A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
8 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) P31696 (/TAS) P31696 (/TAS) P31696 (/TAS) |
|
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
|
8 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) O00468 (/IMP) O00468 (/IMP) O00468 (/IMP) O00468 (/IMP) O00468 (/IMP) |
|
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
|
8 | P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P31696 (/ISS) P31696 (/ISS) P31696 (/ISS) |
|
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
8 | O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) P31696 (/ISS) P31696 (/ISS) P31696 (/ISS) |
|
Retinoid metabolic process GO:0001523
The chemical reactions and pathways involving retinoids, any member of a class of isoprenoids that contain or are derived from four prenyl groups linked head-to-tail. Retinoids include retinol and retinal and structurally similar natural derivatives or synthetic compounds, but need not have vitamin A activity.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Regulation of protein phosphorylation GO:0001932
Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
5 | P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) |
|
Glycosaminoglycan catabolic process GO:0006027
The chemical reactions and pathways resulting in the breakdown of glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
G-protein coupled acetylcholine receptor signaling pathway GO:0007213
Any series of molecular signals initiated by an acetylcholine receptor on the surface of the target cell binding to one of its physiological ligands, and proceeding with the activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction and ends with regulation of a downstream cellular process, e.g. transcription.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Chemical synaptic transmission GO:0007268
The vesicular release of classical neurotransmitter molecules from a neuron, across a chemical synapse, the subsequent activation of neurotransmitter receptors of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
|
5 | P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) |
|
Synapse assembly GO:0007416
The aggregation, arrangement and bonding together of a set of components to form a synapse. This process ends when the synapse is mature (functional).
|
5 | P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) |
|
Glycosaminoglycan metabolic process GO:0030203
The chemical reactions and pathways involving glycosaminoglycans, any one of a group of polysaccharides that contain amino sugars. Formerly known as mucopolysaccharides, they include hyaluronic acid and chondroitin, which provide lubrication in joints and form part of the matrix of cartilage. The three-dimensional structure of these molecules enables them to trap water, which forms a gel and gives glycosaminoglycans their elastic properties.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Positive regulation of GTPase activity GO:0043547
Any process that activates or increases the activity of a GTPase.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Clustering of voltage-gated sodium channels GO:0045162
The process in which voltage-gated sodium channels become localized together in high densities. In animals, nodes of Ranvier differ dramatically from internodal axonal regions in very high densities of voltage-dependent sodium (Nav) channels responsible for the rapid, inward ionic currents that produce membrane depolarization.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Synapse organization GO:0050808
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Protein heterotetramerization GO:0051290
The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Regulation of microtubule cytoskeleton organization GO:0070507
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Skeletal muscle acetylcholine-gated channel clustering GO:0071340
The accumulation of acetylcholine-gated cation channels in a narrow, central region of muscle fibers, in apposition to nerve terminals.
|
5 | P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) P25304 (/IMP) |
|
Regulation of axon guidance GO:1902667
Any process that modulates the frequency, rate or extent of axon guidance.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Plasma membrane organization GO:0007009
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the plasma membrane.
|
3 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) |
|
Chemical synaptic transmission GO:0007268
The vesicular release of classical neurotransmitter molecules from a neuron, across a chemical synapse, the subsequent activation of neurotransmitter receptors of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Neuromuscular junction development GO:0007528
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction.
|
3 | A2ASQ1 (/IGI) A2ASQ1 (/IGI) A2ASQ1 (/IGI) |
|
Regulation of synaptic growth at neuromuscular junction GO:0008582
Any process that modulates the frequency, rate or extent of synaptic growth at neuromuscular junctions.
|
3 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) |
|
Actin cytoskeleton reorganization GO:0031532
A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.
|
3 | P31696 (/TAS) P31696 (/TAS) P31696 (/TAS) |
|
Positive regulation of protein binding GO:0032092
Any process that activates or increases the frequency, rate or extent of protein binding.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Regulation of GTPase activity GO:0043087
Any process that modulates the rate of GTP hydrolysis by a GTPase.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
|
3 | A2ASQ1 (/IGI) A2ASQ1 (/IGI) A2ASQ1 (/IGI) |
|
Receptor clustering GO:0043113
The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
3 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) |
|
Neurotransmitter receptor metabolic process GO:0045213
The chemical reactions and pathways involving neurotransmitter receptors.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Positive regulation of synaptic growth at neuromuscular junction GO:0045887
Any process that activates or increases the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
3 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) |
|
Filopodium assembly GO:0046847
The assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Regulation of cardiac muscle contraction GO:0055117
Any process that modulates the frequency, rate or extent of cardiac muscle contraction.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Positive regulation of protein tyrosine kinase activity GO:0061098
Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Regulation of cardiac muscle cell membrane potential GO:0086036
Any process that modulates the establishment or extent of a membrane potential in a cardiac muscle cell (a cardiomyocyte). A membrane potential is the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Negative regulation of sodium ion export from cell GO:1903277
Any process that stops, prevents or reduces the frequency, rate or extent of sodium ion export from cell.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Negative regulation of sodium:potassium-exchanging ATPase activity GO:1903407
Any process that stops, prevents or reduces the frequency, rate or extent of sodium:potassium-exchanging ATPase activity.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Positive regulation of protein geranylgeranylation GO:2000541
Any process that activates or increases the frequency, rate or extent of protein geranylgeranylation.
|
3 | A2ASQ1 (/IMP) A2ASQ1 (/IMP) A2ASQ1 (/IMP) |
|
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
2 | O95633 (/IDA) Q9EQC7 (/IDA) |
|
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | Q99PW7 (/IEP) |
|
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
1 | O95633 (/IDA) |
|
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
1 | Q9EQC7 (/ISO) |
|
Regulation of transcription from RNA polymerase II promoter GO:0006357
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | O95633 (/IDA) |
|
Regulation of transcription from RNA polymerase II promoter GO:0006357
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q9EQC7 (/ISO) |
|
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
1 | Q99PW7 (/IEP) |
|
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | Q99PW7 (/IEP) |
|
Positive regulation of cell-cell adhesion GO:0022409
Any process that activates or increases the rate or extent of cell adhesion to another cell.
|
1 | O95633 (/IDA) |
|
Positive regulation of cell-cell adhesion GO:0022409
Any process that activates or increases the rate or extent of cell adhesion to another cell.
|
1 | Q9EQC7 (/ISO) |
|
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | Q99PW7 (/IEP) |
|
Adrenal gland development GO:0030325
The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells.
|
1 | Q99PW7 (/IEP) |
|
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
1 | Q9EQC7 (/ISO) |
|
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
1 | O95633 (/IDA) |
|
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
1 | Q9EQC7 (/ISO) |
|
Post-translational protein modification GO:0043687
The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
|
1 | O95633 (/TAS) |
|
Cellular protein metabolic process GO:0044267
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
|
1 | O95633 (/TAS) |
|
Negative regulation of osteoclast differentiation GO:0045671
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.
|
1 | O95633 (/IDA) |
|
Negative regulation of osteoclast differentiation GO:0045671
Any process that stops, prevents, or reduces the frequency, rate or extent of osteoclast differentiation.
|
1 | Q9EQC7 (/ISO) |
|
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q9EQC7 (/ISO) |
|
Cellular response to metal ion GO:0071248
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a metal ion stimulus.
|
1 | Q99PW7 (/IEP) |
|
Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090101
Any process that decreases the rate, frequency, or extent of the series of molecular signals generated as a consequence of a transmembrane receptor serine/threonine kinase binding to its physiological ligand.
|
1 | O95633 (/IDA) |
|
Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway GO:0090101
Any process that decreases the rate, frequency, or extent of the series of molecular signals generated as a consequence of a transmembrane receptor serine/threonine kinase binding to its physiological ligand.
|
1 | Q9EQC7 (/ISO) |
There are 40 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
| GO Term | Annotations | Evidence |
|---|---|---|
|
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
17 |
A2ASQ1 (/TAS)
A2ASQ1 (/TAS)
A2ASQ1 (/TAS)
O00468 (/TAS)
O00468 (/TAS)
O00468 (/TAS)
O00468 (/TAS)
O00468 (/TAS)
O95633 (/TAS)
P25304 (/TAS)
(7 more) |
|
Basal lamina GO:0005605
A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
|
17 |
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
G5EG68 (/IDA)
O00468 (/IDA)
(7 more) |
|
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
|
16 |
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
P25304 (/IDA)
P25304 (/IDA)
(6 more) |
|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
14 |
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A0A1D5PHC7 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
A2ASQ1 (/IDA)
O95633 (/IDA)
P31696 (/IDA)
(4 more) |
|
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
8 | A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) A0A1D5PHC7 (/IMP) P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Basement membrane GO:0005604
A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
|
8 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Basal lamina GO:0005605
A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
|
8 | P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P25304 (/ISS) P31696 (/ISS) P31696 (/ISS) P31696 (/ISS) |
|
Golgi lumen GO:0005796
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
|
8 | A2ASQ1 (/TAS) A2ASQ1 (/TAS) A2ASQ1 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
8 | O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
8 | A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
|
8 | A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) A0A1D5PHC7 (/TAS) P31696 (/TAS) P31696 (/TAS) P31696 (/TAS) |
|
Neuromuscular junction GO:0031594
The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential.
|
8 | A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
8 | A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) A0A1D5PHC7 (/IDA) P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
|
8 | O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) O00468 (/ISS) P31696 (/ISS) P31696 (/ISS) P31696 (/ISS) |
|
Proteinaceous extracellular matrix GO:0005578
A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus.
|
5 | P25304 (/TAS) P25304 (/TAS) P25304 (/TAS) P25304 (/TAS) P25304 (/TAS) |
|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
5 | O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) |
|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
|
5 | O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) |
|
Lysosomal lumen GO:0043202
The volume enclosed within the lysosomal membrane.
|
5 | O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) O00468 (/TAS) |
|
Axonal growth cone GO:0044295
The migrating motile tip of a growing nerve cell axon.
|
5 | P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) P25304 (/IDA) |
|
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
5 | O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) O00468 (/IDA) |
|
Basal lamina GO:0005605
A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
|
3 | P31696 (/IMP) P31696 (/IMP) P31696 (/IMP) |
|
Basal lamina GO:0005605
A thin sheet of proteoglycans and glycoproteins, especially laminin, secreted by cells as an extracellular matrix.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
3 | A2ASQ1 (/TAS) A2ASQ1 (/TAS) A2ASQ1 (/TAS) |
|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Synaptic cleft GO:0043083
The narrow gap that separates the presynaptic and postsynaptic membranes, into which neurotransmitter is released.
|
3 | A2ASQ1 (/IDA) A2ASQ1 (/IDA) A2ASQ1 (/IDA) |
|
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
3 | P31696 (/IDA) P31696 (/IDA) P31696 (/IDA) |
|
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
3 | A2ASQ1 (/ISO) A2ASQ1 (/ISO) A2ASQ1 (/ISO) |
|
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
2 | A0A024R1Y8 (/IDA) O95633 (/IDA) |
|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | Q9EQC7 (/ISO) |
|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | O95633 (/IDA) |
|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q9EQC7 (/ISO) |
|
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
1 | Q9EQC7 (/ISO) |
|
Endoplasmic reticulum lumen GO:0005788
The volume enclosed by the membranes of the endoplasmic reticulum.
|
1 | O95633 (/TAS) |
|
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | Q99PW7 (/IDA) |
|
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
1 | Q99PW7 (/IDA) |
|
Neuron projection terminus GO:0044306
The specialized, terminal region of a neuron projection such as an axon or a dendrite.
|
1 | Q99PW7 (/IDA) |
